The current perception is that new drugs rely on old delivery technologies to get past the regulatory authorities, whereas old drugs look to new techniques to survive.<(p>

This report examines the current and future trends that are shaping the drug delivery market and reviews the key emerging technologies across major systems of drug delivery.

This report is an up-to-date guide that assesses the current state of the drug delivery industry and its application to both the pharmaceutical and biotech industries.

The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, needle-free injectors and inhalers. It also takes into account pros and cons of each device and gives a detailed analysis on their futu

An analysis of key technologies and products’ reveals the value of enhanced drug delivery in improving treatment outcomes, differentiating between products, optimizing the patented revenue potential of a drug and maximizing the ROI in new chemica

Currently driven by the needs of the expanding respiratory market, the inhalable drug delivery sector has also been invigorated by the promise of growth through the systemic delivery of drugs via the lungs as the first inhalable insulin nears the marke

The protein therapeutic market is forecast to grow rapidly at a CAGR of 10.5% from 2003 to 2010, to almost double in value. The increased use, development and discovery of protein therapeutics will lead to increasing opportunities for drug delivery com

Datamonitor’s Drug Delivery: Global Industry Guide is an essential resource for top-level data and analysis covering the drug delivery industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and com

The injectable drug delivery market is growing. Rising 16.3% to an estimated $83 billion in 2002, it is forecast to grow at a CAGR of 10% between 2002 and 2008. The increasing use of reformulation techniques earlier in product lifecycles is changing th

This report will provide a completely up-to-date perspective of the drug delivery sector. It includes over 1400 drug delivery deals, over 50 drug delivery contracts and the latest company information.

An up-to-date guide that assesses the current state of the drug delivery industry and its application to both the pharmaceutical and biotech industries.

Identify the latest dealmaking trends in your industry

Use this report to understand how nanotechnology and other key technologies are changing drug delivery and how these can be implemented into your R&D process.

The success of protein and peptide therapeutics is revolutionizing the biotech and pharmaceutical market, spurring the creation of next-generation products with reduced immunogenicity, improved safety and greater effectiveness.